UFP Technologies, Inc. (UFPT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$329.82+17.66%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · UFPT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 59.3% |
| Our one-year growth estimate | diamond | 9.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 50.1 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 28 industry peers · Company calendar date is not available
UFPT — General Counsel transition
Dated 2026-05-26
General Counsel, Secretary, and Senior Vice President of Human Resources — Christopher P. Litterio: General Counsel, Secretary, and Senior Vice President of Human Resources plans to retire after a period of transition.
Why it matters: Non-medical sales fell 15% in Q1 and were flat in Q2. Another drop would weigh on growth outside MedTech.
Worry ifNon-medical sales fall year over year in the next report after Q2's flat result.
Less concerning ifNon-medical sales rise year over year in the next report.
Why it matters: Q2 sales rose 15.1%, after Q1 sales rose 4.1%. Another strong quarter would show growth held up.
Supportive ifIn the Q3 report, sales rise more than 10% from the same quarter in 2025.
Worry ifIn the Q3 report, sales rise less than 5% from the same quarter in 2025, or fall.
Why it matters: The programs added start-up costs in Q1. Management said they may make a large contribution in the second half.
Supportive ifA company update links higher sales or profit to the four programs. Second-half results improve from the first half.
Worry ifA company update says the programs are delayed. Or second-half results show no sales or profit gains tied to them.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$124 on $10,000 · ±1.2% | How much price usually moves either way. |
| Bad day | $374 loss on $10,000 · 3.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,069 loss on $10,000 · 30.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.